173 related articles for article (PubMed ID: 9513708)
21. Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects.
Ingman WV; Robertson SA
Biol Reprod; 2008 Oct; 79(4):711-7. PubMed ID: 18614704
[TBL] [Abstract][Full Text] [Related]
22. TNF signaling via the ligand-receptor pair ectodysplasin and edar controls the function of epithelial signaling centers and is regulated by Wnt and activin during tooth organogenesis.
Laurikkala J; Mikkola M; Mustonen T; Aberg T; Koppinen P; Pispa J; Nieminen P; Galceran J; Grosschedl R; Thesleff I
Dev Biol; 2001 Jan; 229(2):443-55. PubMed ID: 11203701
[TBL] [Abstract][Full Text] [Related]
23. Wingless, the Drosophila homolog of the proto-oncogene Wnt-1, can transform mouse mammary epithelial cells.
Ramakrishna NR; Brown AM
Dev Suppl; 1993; ():95-103. PubMed ID: 8049493
[TBL] [Abstract][Full Text] [Related]
24. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis.
Sebastian J; Richards RG; Walker MP; Wiesen JF; Werb Z; Derynck R; Hom YK; Cunha GR; DiAugustine RP
Cell Growth Differ; 1998 Sep; 9(9):777-85. PubMed ID: 9751121
[TBL] [Abstract][Full Text] [Related]
25. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
26. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A
Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720
[TBL] [Abstract][Full Text] [Related]
27. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic potential of erbB-2 in human mammary epithelial cells.
Pierce JH; Arnstein P; DiMarco E; Artrip J; Kraus MH; Lonardo F; Di Fiore PP; Aaronson SA
Oncogene; 1991 Jul; 6(7):1189-94. PubMed ID: 1713661
[TBL] [Abstract][Full Text] [Related]
29. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
30. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
31. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V
J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561
[TBL] [Abstract][Full Text] [Related]
32. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
33. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
[TBL] [Abstract][Full Text] [Related]
34. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth.
Andrechek ER; White D; Muller WJ
Oncogene; 2005 Jan; 24(5):932-7. PubMed ID: 15580295
[TBL] [Abstract][Full Text] [Related]
35. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland.
Schroeder JA; Lee DC
Cell Growth Differ; 1998 Jun; 9(6):451-64. PubMed ID: 9663464
[TBL] [Abstract][Full Text] [Related]
36. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.
Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R
Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447
[TBL] [Abstract][Full Text] [Related]
37. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.
Silberstein GB; Van Horn K; Hrabeta-Robinson E; Compton J
J Endocrinol; 2006 Aug; 190(2):225-39. PubMed ID: 16899557
[TBL] [Abstract][Full Text] [Related]
38. Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation.
Brandt R; Eisenbrandt R; Leenders F; Zschiesche W; Binas B; Juergensen C; Theuring F
Oncogene; 2000 Apr; 19(17):2129-37. PubMed ID: 10815804
[TBL] [Abstract][Full Text] [Related]
39. Specific protection against breast cancers by cyclin D1 ablation.
Yu Q; Geng Y; Sicinski P
Nature; 2001 Jun; 411(6841):1017-21. PubMed ID: 11429595
[TBL] [Abstract][Full Text] [Related]
40. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
